| Literature DB >> 35224659 |
Rupesh Raina1,2, Rolla Abu-Arja3,4, Sidharth Sethi5, Richa Dua6, Ronith Chakraborty7, James T Dibb8, Rajit K Basu9, John Bissler10, Melvin Bonilla Felix11, Patrick Brophy12, Timothy Bunchman13, Khalid Alhasan14, Dieter Haffner15, Yap Hui Kim16,17, Christopher Licht18, Mignon McCulloch19, Shina Menon20, Ali Mirza Onder21,22, Prajit Khooblall23, Amrit Khooblall7, Veronika Polishchuk3,4, Hemalatha Rangarajan3,4, Azmeri Sultana24, Clifford Kashtan25.
Abstract
Hematopoietic cell transplantation (HCT) is a common therapy for the treatment of neoplastic and metabolic disorders, hematological diseases, and fatal immunological deficiencies. HCT can be subcategorized as autologous or allogeneic, with each modality being associated with their own benefits, risks, and post-transplant complications. One of the most common complications includes acute kidney injury (AKI). However, diagnosing HCT patients with AKI early on remains quite difficult. Therefore, this evidence-based guideline, compiled by the Pediatric Continuous Renal Replacement Therapy (PCRRT) working group, presents the various factors that contribute to AKI and recommendations regarding optimization of therapy with minimal complications in HCT patients.Entities:
Keywords: Acute kidney injury; Bone marrow transplant; Hematopoietic cell transplantation; KRT; Pediatrics; Transplant
Mesh:
Year: 2022 PMID: 35224659 DOI: 10.1007/s00467-022-05448-x
Source DB: PubMed Journal: Pediatr Nephrol ISSN: 0931-041X Impact factor: 3.651